Nano-X Imaging Ltd. current report, Q3 FY2023

Nano-X Imaging Ltd. Form 6-K Summary

Business context and reporting period

Nano-X Imaging Ltd. filed this Form 6-K on August 17, 2023, covering the month of August 2023. The filing reports a press release furnished as Exhibit 99.1 and discusses financial-statement corrections, internal-control remediation, regulatory matters, and pending litigation.

Financial metrics and liquidity

  • The filing text provided does not include clear figures for revenue, net income or loss, operating cash flow, margins, debt, cash balances, or liquidity.
  • The Company corrected the classification of approximately $13.56 million in second-quarter 2022 cash-flow items. Approximately $12.5 million was reclassified to investing activities, and approximately $1.06 million was reclassified to operating activities.
  • The cash-flow correction had no impact on the Company’s overall cash position as of June 30, 2022.
  • The Company used certain non-GAAP measures in the related press release. These measures exclude, among other items, legal and related expenses; the filing refers investors to the press release for the full reconciliation and excluded items.

Material changes versus the prior comparable period

  • The previously reported second-quarter 2022 cash-flow statement was retroactively corrected to address an error in the classification of marketable-securities transactions and related amortization.
  • The correction was associated with previously disclosed material weaknesses in internal control over financial reporting, but did not change total cash.
  • The Company entered into a formal $8 million settlement agreement on June 2, 2023, covering shareholder class actions related to the McLaughlin action and the consolidated White action. The settlement remains subject to court approval and other conditions.

Guidance, outlook, risks, contingencies, and unusual items

  • The Company is remediating its material weaknesses by enhancing and supplementing its finance team and internal-control resources.
  • The SEC is investigating, among other matters, the development cost of Nanox.ARC prototypes and estimates for assembling the product at scale. The Company and Chairman Ran Poliakine reached agreements in principle with SEC staff, subject to final documentation, Company and SEC approvals, and federal court approval.
  • The Company estimates potential SEC-related civil penalties of approximately $650,000 for the Company and less than $500,000 in penalties, disgorgement, and prejudgment interest for Mr. Poliakine. Final terms, timing, and authorization are uncertain.
  • The White and McLaughlin securities class actions remain subject to settlement approval. The White action also includes outstanding procedural matters, while the motion to dismiss in the McLaughlin action remains pending.
  • On May 1, 2023, the Company received a claim seeking approximately $1.26 million in unpaid consulting fees and approximately $25 million relating to alleged entitlement to securities in Nanox Gibraltar PLC. The Company disputes the allegations and intends to defend the matter.

Most important facts for investors to verify

  • Obtain Exhibit 99.1 to review the omitted revenue, earnings, cash-flow, liquidity, and non-GAAP reconciliation details.
  • Track final SEC settlement documentation, penalties, disgorgement, court approval, and any related accounting effects.
  • Confirm court approval and funding of the $8 million shareholder litigation settlement.
  • Monitor the remediation of material weaknesses and whether future filings report additional control deficiencies or restatements.
  • Assess the status and potential exposure from the Gibraltar-related consulting and securities claim.